Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis

BACKGROUND: Short-course, rifamycin-based regimens could facilitate scale-up of tuberculosis preventive therapy (TPT), but it is unclear how stringently tuberculosis (TB) disease should be ruled out before TPT use. METHODS: We developed a state-transition model of a TPT intervention among two TPT-el...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendall, Emily A., Hussain, Hamidah, Kunkel, Amber, Kubiak, Rachel W., Trajman, Anete, Menzies, Richard, Drain, Paul K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670249/
https://www.ncbi.nlm.nih.gov/pubmed/34903214
http://dx.doi.org/10.1186/s12916-021-02189-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670249/
https://www.ncbi.nlm.nih.gov/pubmed/34903214
http://dx.doi.org/10.1186/s12916-021-02189-w

Ejemplares similares